CHI’s Clinical Genomics for Cancer Diagnostics conference will take place from September 23-24 in Boston.
The meeting will be a forum to learn more about new diagnostic tools and techniques. Hotspot testing will be compared to comprehensive genome profiling, emerging technologies will be explored, including molecular test development.
- “Integrated Genomic Data Informs Cancer Treatment”—Elaine R. Mardis, PhD, professor, Genetics and Molecular Microbiology; Co-Director, The Genome Institute, Washington University School of Medicine at Washington University Medical Center
- “Solving the ‘Big Data’ Challenge at the Interface of Science and Medicine”—John Quackenbush, PhD, professor, Biostatistics and Computational Biology, Cancer Biology Center for Cancer, Dana-Farber Cancer Institute
- ??”Validation and Clinical Application of a Cancer Genomic Profiling Test Using Next-Generation Sequencing Reveals the Landscape of Clinically Actionable Tumor Alterations”—Phil Stephens, PhD, VP, Cancer Genomics, Foundation Medicine
- “Individual Patient Full-Genome Cancer Profiling for Optimized Treatment Strategies”—Raphael Lehrer, Founder and Chief Scientist, GeneKey
- ??”Clinical Genomics in a Breast Cancer Multidisciplinary Tumor Board”—Peter J. Tonellato, PhD, Director, Laboratory for Personalized Medicine, Center for Biomedical Informatics, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School
- “Personalized, Precision Lung Cancer Medicine through Integrated Genomic Analysis”—Trever Bivona, MD, PhD, assistant professor, Medicine/Hematology-Oncology, University of California, San Francisco
Click here to see the full schedule.